Vor Biopharma (VOR) Non-Current Assets (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Non-Current Assets data on file, last reported at $6.0 million in Q1 2026.

• Quarterly Non-Current Assets fell 86.58% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.2 million (down 91.52% YoY) and the FY2025 annual result came in at $6.0 million, down 87.02% from the prior year.
• Non-Current Assets fell to $6.0 million in Q1 2026 per VOR's latest filing, from $6.0 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $65.8 million in Q2 2022 and bottomed at $444000.0 in Q2 2025.
• The 5-year median for Non-Current Assets is $51.3 million (2024), against an average of $43.2 million.
• The widest annual swing landed in 2022, when Non-Current Assets soared 154.16%; it then slumped 99.14% in 2025.
• Tracing VOR's Non-Current Assets over 5 years: stood at $62.4 million in 2022, then declined by 8.16% to $57.3 million in 2023, then retreated by 19.08% to $46.4 million in 2024, then slumped by 87.02% to $6.0 million in 2025, then decreased by 0.88% to $6.0 million in 2026.
• Per Business Quant, the three latest VOR Non-Current Assets figures stand at $6.0 million (Q1 2026), $6.0 million (Q4 2025), and $3.8 million (Q3 2025).

Peer Comparison